We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.71B
AUM Growth
-$44.3M
Cap. Flow
-$66.1M
Cap. Flow %
-2.44%
Top 10 Hldgs %
17.98%
Holding
299
New
64
Increased
62
Reduced
142
Closed
18

Top Sells

Rank Stock Value
1
CHGG icon
Chegg
CHGG
+$22.7M
2
TREX icon
Trex
TREX
+$17.5M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$15.4M
4
TTEK icon
Tetra Tech
TTEK
+$15.3M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$15.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 17.94%
3 Consumer Discretionary 17%
4 Industrials 15.63%
5 Financials 14.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTLO icon
101
Portillo's
PTLO
$326M
$8.25M 0.3%
+219,830
New +$8.81M
RIOT icon
102
Riot Platforms
RIOT
$7.43B
$8.01M 0.3%
+358,837
New +$10.7M
MASS icon
103
908 Devices
MASS
$293M
$7.78M 0.29%
300,824
+168,055
+127% +$4.94M
MSFT icon
104
Microsoft
MSFT
$2.97T
$7.67M 0.28%
22,817
-399
-2% -$129K
CCNE icon
105
CNB Financial Corp
CCNE
$1.01B
$7.58M 0.28%
286,026
+22,849
+9% +$599K
ARIS
106
DELISTED
Aris Water Solutions
ARIS
$7.56M 0.28%
+584,080
New +$7.76M
OCUL icon
107
Ocular Therapeutix
OCUL
$1.92B
$7.37M 0.27%
1,057,727
+208,127
+24% +$1.62M
TMCI icon
108
Treace Medical Concepts
TMCI
$276M
$7.06M 0.26%
378,928
+107,051
+39% +$2.21M
MAX icon
109
MediaAlpha
MAX
$776M
$6.54M 0.24%
423,726
-190,035
-31% -$3.17M
BW icon
110
Babcock & Wilcox
BW
$1.52B
$6.33M 0.23%
702,223
+394,971
+129% +$3.16M
APLT
111
DELISTED
Applied Therapeutics
APLT
$5.47M 0.2%
611,525
+45,797
+8% +$601K
RETA
112
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.72M 0.17%
178,872
-97,283
-35% -$7.53M
TMDX icon
113
Transmedics
TMDX
$2.52B
$4.69M 0.17%
244,816
-8,562
-3% -$215K
NVDA icon
114
NVIDIA
NVDA
$5T
$4.63M 0.17%
157,510
-8,370
-5% -$230K
CVRX icon
115
CVRx
CVRX
$125M
$4.49M 0.17%
367,216
-9,095
-2% -$132K
PAYA
116
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$4.42M 0.16%
697,221
-235,259
-25% -$1.91M
ZVIA icon
117
Zevia
ZVIA
$119M
$4.4M 0.16%
623,557
-21,173
-3% -$207K
UDMY
118
DELISTED
Udemy
UDMY
$4.36M 0.16%
+222,870
New +$5.33M
THRN
119
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$4.3M 0.16%
693,030
+251,140
+57% +$1.96M
AMZN icon
120
Amazon
AMZN
$2.71T
$4.24M 0.16%
25,420
GOOGL icon
121
Alphabet (Google) Class A
GOOGL
$4.34T
$3.86M 0.14%
26,640
-2,640
-9% -$380K
ANIP icon
122
ANI Pharmaceuticals
ANIP
$1.77B
$3.82M 0.14%
+82,944
New +$3.56M
ENFN
123
DELISTED
Enfusion, Inc.
ENFN
$3.54M 0.13%
+169,070
New +$3.42M
GNRC icon
124
Generac Holdings
GNRC
$12.6B
$3.42M 0.13%
9,717
+2,049
+27% +$850K
HZNP
125
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.17M 0.12%
29,439
-2,406
-8% -$262K

Similar funds

Emerald Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Emerald Advisers held 299 positions worth $2.71B, down 1.6% from $2.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q4 2021 filing shows 64 new, 62 increased, 142 reduced and 18 closed positions. Its largest new stake was Herc Holdings: 116,724 shares worth $18.3M. The largest sale was Chegg, an estimated $22.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2021 buy was Herc Holdings: 116,724 shares worth $18.3M.
  • Emerald Advisers added most to Customers Bancorp in Q4 2021, an estimated $17.9M increase.
  • Emerald Advisers's biggest Q4 2021 reduction was Chegg, cutting an estimated $22.7M.
  • Emerald Advisers fully exited Oric Pharmaceuticals in Q4 2021, selling an estimated $15.2M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.71B portfolio in Q4 2021.
  • Emerald Advisers opened 64 new positions and closed 18 in Q4 2021.
  • Emerald Advisers's portfolio value fell 1.6% quarter-over-quarter to $2.71B.

Based on Emerald Advisers's 13F filing for Q4 2021, filed 2 Feb 2022.